Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04051515
Other study ID # HoBIDnurse
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 9, 2019
Est. completion date November 29, 2019

Study information

Verified date January 2021
Source Cardenal Herrera University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Participants will be randomized either to home-based exercise or to intradialysis exercise guided by nurses of the renal unit. The programs will last 16 weeks. The intradialysis exercise consists of combined aerobic and resistance training exercise. The home-based exercise consists of resistance exercise and walking.


Description:

During 16 weeks one group will follow an intradialysis exercise program. The exercise program consists of strengthening exercises for lower limbs and for the upper limb free of fistula. The exercise program includes isotonic exercises for quadriceps, triceps surae, psoas, glutei, and brachial biceps; and isometric exercises for hip adductors and hamstrings. Elastic bands will be used to apply resistance. Progression will be achieved by increasing from 1 set of 10 repetitions until 3 sets of 15 repetitions. This first part of the exercise session will last no more than 30 minutes. The program will also include aerobic exercise (cycling) for up to 30 minutes. Intensity will adapted through the duration of the study so that the participant feel the exercise from hard to somewhat hard (13 to 15 at the rate of perceived exertion 6 to 20). Time and resistance will be adapted progressively. After an initial training period by a physiotherapist, the nursing staff will be responsible for monitoring and implementing the program. The other group will follow a home-based program. A booklet with resistance exercise and recommendation of walking between exercises will be provided. An initial training phase will be applied by the physiotherapists from the rehabilitation department.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date November 29, 2019
Est. primary completion date November 29, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Patients on hemodialysis medically stable, be able to walk at least a few steps, even if you need walking aids like canes or a walker. Life expectancy greater than 6 months Exclusion Criteria: 1. Myocardial infarction in the previous 6 weeks 2. Angina unstable on exercise or at rest 3. Brain injury derived from a cardiovascular problem. Cerebral vascular disease such as stroke in the last 6 months or with relevant sequelae in lower limb mobility presenting hemiparesia. 4. Life expectancy less than 6 months 5. Cognitive impairment 6. Language barriers 7. Illiteracy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Intradialysis exercise training
Combined exercise, aerobic and resistance training, implemented by nursing staff
Home-based exercise training
Combined exercise, aerobic and resistance training, implemented independently home

Locations

Country Name City State
Belgium KU Leuven Leuven
Greece Aristotle University of Thessaloniki Thessaloníki
Spain Hospital de Manises Manises Valencia
Spain Universiat de Valéncia Valencia
Spain Universitat de Valencia Valencia
Sweden Skane Univeristy Hospital Lund
Sweden Karolinska Institute Stockholm

Sponsors (2)

Lead Sponsor Collaborator
Cardenal Herrera University Hospital de Manises

Countries where clinical trial is conducted

Belgium,  Greece,  Spain,  Sweden, 

References & Publications (4)

Ortega-Pérez de Villar L, Martínez-Olmos FJ, Junqué-Jiménez A, Amer-Cuenca JJ, Martínez-Gramage J, Mercer T, Segura-Ortí E. Test-retest reliability and minimal detectable change scores for the short physical performance battery, one-legged standing test and timed up and go test in patients undergoing hemodialysis. PLoS One. 2018 Aug 22;13(8):e0201035. doi: 10.1371/journal.pone.0201035. eCollection 2018. — View Citation

Segura-Orti E, Johansen KL. Exercise in end-stage renal disease. Semin Dial. 2010 Jul-Aug;23(4):422-30. doi: 10.1111/j.1525-139X.2010.00766.x. Review. — View Citation

Segura-Ortí E, Martínez-Olmos FJ. Test-retest reliability and minimal detectable change scores for sit-to-stand-to-sit tests, the six-minute walk test, the one-leg heel-rise test, and handgrip strength in people undergoing hemodialysis. Phys Ther. 2011 Aug;91(8):1244-52. doi: 10.2522/ptj.20100141. Epub 2011 Jun 30. — View Citation

Segura-Ortí E. [Exercise in haemodyalisis patients: a literature systematic review]. Nefrologia. 2010;30(2):236-46. doi: 10.3265/Nefrologia.pre2010.Jan.10229. Epub 2010 Jan 21. Review. Spanish. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline short physical performance battery at 16 weeks Score achieved at the battery that includes balance tests (4 points), sit to stand to sit 5 (4 points) and and gait speed (4 points). The total score is calculated , from 1 to 12, being 12 the highest functional score Baseline, 16 weeks
Primary Change from baseline gait speed at 16 weeks Speed to cover 4 meters, in meters/second Baseline, 16 weeks
Secondary Change from baseline sit to stand 10 test at 16 weeks Time to perform 10 repetitions sit to stand Baseline, 16 weeks
Secondary Change from baseline sit to stand 60 test at 16 weeks Sit to stand repetitions performed in 60 seconds Baseline, 16 weeks
Secondary Change from baseline 6 minutes walk test at 16 weeks Number of meters walked in 6 minutes Baseline, 16 weeks
Secondary Change from baseline handgrip strength at 16 weeks Bilateral handgrip strength Baseline, 16 weeks
Secondary Change from baseline one-leg heel rise test at 16 weeks Number of heel rise repetitions achieved Baseline, 16 weeks
Secondary Change from baseline one-leg standing test at 16 weeks Time achieved while standing on one leg Baseline, 16 weeks
Secondary Change from baseline timed up and go test at 16 weeks Time to stand up, walk 3 meters, come back and sit down again Baseline, 16 weeks
Secondary Change from baseline Physical activity level at 16 weeks Physical activity questionnaires Baseline, 16 weeks
Secondary Change from baseline Health related quality of life at 16 weeks Medical outcomes survey Short Form 36 questionnaire to measure health-related quality of life, rated from 0 to 100, being the highest score the better the quality of life Baseline, 16 weeks
Secondary Adherence, as number of sessions performed /number of sessions offered Sessions performed/sessions offered 16 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05978479 - The Effect of Individualized Education Using the Teach-Back Method Treatment on Treatment Adherence and the Coping Skills N/A
Completed NCT06022835 - Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis N/A
Completed NCT05540457 - Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis) N/A
Recruiting NCT04046042 - Virtual Reality Intradialysis: Last vs. First Part of the Session N/A
Not yet recruiting NCT04527640 - Effects of Synbiotics Supplementation on the Uremic Toxin Indoxyl Sulfate Level and Constipation in End-stage Renal Disease Patients Undergoing Hemodialysis N/A
Completed NCT05947708 - The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300 N/A
Recruiting NCT05735743 - MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence N/A
Completed NCT04505462 - Dietary Therapy in Dialysis Patients N/A
Active, not recruiting NCT04546958 - Nutritional Interventions in Peritoneal Dialysis Patients With Hypoalbuminemia N/A
Recruiting NCT04286477 - The Immune System in End Stage CKD Patients - Comparison Among Different Modalities of RRT
Completed NCT04487301 - A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
Recruiting NCT05677555 - Colchicine and Inflammation in Hemodialysis Patients Phase 2
Completed NCT04789876 - Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia N/A
Completed NCT04125537 - Pathways Project: Kidney Supportive Care
Suspended NCT05915286 - Diuretic Use in Hemodialysis Patients With Residual Renal Function Phase 4
Completed NCT04912050 - EXtension of Tablo TrEatmeNt Duration Registry
Recruiting NCT04360694 - RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE) N/A
Recruiting NCT04501159 - pH, Hypoxia and Haemodialysis
Recruiting NCT05032651 - Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients N/A
Completed NCT04806126 - Evaluation of a Virtual Home Dialysis Mentoring Program (Home)